Cardiomyopathy in anemia, associated with chronic kidney disease: role of erythropoetin-beta


Cite item

Full Text

Abstract

Pathogenesis, clinical signs and treatment of cardiac involvement in renal anemia are discussed.

References

  1. Ланг Г.Ф. Болезни системы кровообращения. М., 19. С: 181.
  2. Pereira A.A., Sarnak M.J. Anemia as a risk factor for cardiovascular disease. Kidney Int. Suppl. 2003; 87: 32-39.
  3. Levin A., Singer J., Thompson C.R. et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am. J. Kidney Dis. 1996; 27: 347-354.
  4. Herzog C.A., Muster H.A., Li S., Collins A.J. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail. 2004; 10(6): 467-472.
  5. McClellan W., Flanders W.D., Langston R.D. et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J. Am. Soc. Nephrol. 2002; 13: 1928-1936.
  6. Ezekowitz J.A., McAlister F.A., Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003;107: 223.
  7. Sarnak M.J., Tighiouart H., Manjunath G. et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J. Am. Coll. Cardiol. 2002; 40: 27-33.
  8. Harnett J.D., Kent G.M., Foley R.M., Parfrey P.M. Cardiac function and haematocrit level. Am. J. Kidney Dis. 1995; 25 (Suppl. 4): S3-S7.
  9. Anand I.S., Chandrashekhar Y., Ferrari R. et al. Pathogenesis of edema in chronic anemia: studies of body water and sodium, renal function, haemodynamics and plasma hormones. Br. Heart J. 1993; 70: 357-362.
  10. Weiskopf R.B., Viele M.K., Feiner J. et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. J.A.M.A. 1998; 279: 217-221.
  11. Welch H.G., Meehan K.R., Goodnough L.T. Prudent strategies for elective red cell blood transfusion. Ann. Intern. Med. 1992; 116: 393-402.
  12. Drüeke T.B., Locatelli F., Clyne N. et al.; CREATE Investigators. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006; 355(20): 2071-2084.
  13. Eckardt K.U., Scherhag A., Macdougall I.C. et al. Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD. J Am Soc Nephrol. 2009; 20(12): 2651-2660.
  14. Schunkert H., Hense H.W. A heart price to pay for anaemia. Nephrol. Dial. Transplant. 2001; 16: 445-448.
  15. Wahr J.A. Myocardial ischemia in anaemic patients. Br. J. Anaesth. 1998; 81 (Suppl. 1): 10-15.
  16. Foley R.N., Parfrey P.S., Harnett J.D. et al. The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am. J. Kidney Dis. 1996; 28: 53-61.
  17. Levin A., Thompson C.R., Ethier J. et al. Left ventricular mass index increase in early renal disease: impact in decline of hemoglobin. Am. J. Kidney Dis. 1999; 34: 125-134.
  18. Greaves S.C., Gamble G.D., Collins J.F. et al. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am. J. Kidney Dis. 1994; 24: 768-776.
  19. Madore F., Lowrie E.G., Brugnara C. et al. Anemia in hemodialysis patients: variables affecting this outcome predictor. J. Am. Soc. Nephrol. 1997; 8: 1921-1929.
  20. Neff M.S., Kwan E.K., Persoff M. et al. Hemodynamics of uremic anemia. Circulation 1971; 43: 876-883.
  21. Jungers P., Massy Z.A., Nguyen Khoa T. et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol. Dial. Transplant. 1997; 12: 2597-2602
  22. Cannella G., LaCanna G., Sandrini M. et al. Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients. Nephol. Dial. Transplant. 1991; 6: 31-37.
  23. Cannella G., La Canna G., Sandrini M. et al. Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients. Clin. Nephrol. 1990; 34(6): 272-278.
  24. Massimetti C., Pontillo D., Feriozzi S. et al. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients. Blood Purif. 1998; 16(6): 317-324.
  25. Hampl H., Hennig L., Rosenberger C. et al. Effects of optimized heart failure therapy and anemia correction with epoetin beta on left ventricular mass in hemodialysis patients. Am J Nephrol. 2005; 25(3): 211-220.
  26. Pappas K.D., Gouva C.D., Katopodis K.P. et al. Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance. Cardiovasc Drugs Ther. 2008; 22(1): 37-44.
  27. Hampl H., Hennig L., Rosenberger C. et al. Optimized heart failure therapy and complete anemia correction on left-ventricular hypertrophy in nondiabetic and diabetic patients undergoing hemodialysis. Kidney Blood Press Res. 2005; 28(5-6): 353-362.
  28. Martinez-Vea A., Bardají A., García C. et al. Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis. Am J Kidney Dis. 1992; 19(4): 353-357.
  29. Möcks J. Cardiovascular mortality in haemodialysis patients treated with epoetin beta - a retrospective study. Nephron. 2000; 86(4): 455-462.
  30. Земченков А.Ю., Вишневский К.А., Герасимчук Р.П. и др. Оценка эффективности и безопасности отечественного препарата эритропоэтина бета. Обзор литературы и отчет об открытом одноцентровом исследовании. Клин. нефрология 2011; 2: 20-26.
  31. Анохина Т.Ю., Митрохин В.Е., Кожевникова Е.Г. и др. Эффективность и безопасность применения препарата эритропоэтин бета для лечения анемии у недоношенных детей. Вопросы практической педиатрии 2010; 5(6): 86-90.
  32. Титова В.А., Крейнина Ю.М., Шипилова А.Н. и др. Эритропоэтины (Эпостим) в сопровождении химиолучевого лечения злокачественных опухолей у больных с анемией. Опухоли женской репродуктивной системы 2010; 3: 45-49.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies